Breaking News, Collaborations & Alliances

Applied Cells Inc. and GenScript USA Enter Strategic Collaboration

Will deliver combined cell isolation solutions for cell therapy drug development worldwide.

Author Image

By: Charlie Sternberg

Associate Editor

Applied Cells Inc. and GenScript USA Incorporated have entered a strategic collaboration to deliver combined cell isolation solutions for cell therapy drug development worldwide.   Under this collaboration, GenScript will develop and supply its proprietary research and cGMP grade CytoSinct reagents for use in developing CAR-T and other Cell Therapy products on the Applied Cells MARS Platform.   GenScript has years of experience on beads development and its own know-how technology on nanopart...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters